首页|养心活血方联合曲美他嗪对老年冠状动脉慢血流患者血流分级及血管内皮功能的影响

养心活血方联合曲美他嗪对老年冠状动脉慢血流患者血流分级及血管内皮功能的影响

扫码查看
目的 探讨养心活血方联合曲美他嗪在老年冠状动脉慢血流(CSF)患者中的应用效果.方法 选取80例烟台市蓬莱中医医院2021年7月至2022年5月收治的老年冠状动脉慢血流患者,按随机数表法分为两组,每组各40例.对照组予以曲美他嗪治疗,观察组加用养心活血方治疗,持续3个月.比较两组临床疗效、冠脉校正的TIMI帧计数(CTFC)、血流分级、血管内皮功能、中医症状积分及不良反应.结果 观察组总有效率较对照组高,治疗后左前降支、左回旋支及右冠状动脉校正的TIMI帧计数低于对照组,差异有统计学意义(P<0.05);观察组血流分级优于对照组(P<0.05);观察组治疗后一氧化氮水平高于对照组,内皮素-1水平低于对照组,差异有统计学意义(P<0.05);观察组治疗后胸痛、胸闷、心悸气短、神疲乏力积分低于对照组,差异有统计学意义(P<0.05);两组不良反应总发生率比较,差异无统计学意义(P>0.05).结论 养心活血方联合曲美他嗪可提高老年CSF治疗效果,改善冠脉CTFC,纠正血流异常,减轻血管内皮功能损伤,降低中医症状积分,安全可靠.
Effect of Yangxin Huoxue recipe combined with trimetazidine on blood flow classification and vascular endothelial function in elderly patients with coronary slow flow
Objective To explore the application effect of Yangxin Huoxue recipe combined with trimetazidine in elderly patients with coronary slow flow(CSF).Methods A total of eighty elderly patients with coronary slow flow admitted to Yantai Penglai Traditional Chinese Medicine Hospital from July 2021 to May 2022 were randomly divided into two groups according to the random number table method,with 40 patients in each group.The control group was treated with trimetazidine for 3 months,while the observation group was treated with Yangxin Huoxue recipe for 3 months.The clinical efficacy,coronary corrected TIM1 frame count(CTFC),blood flow classification,vascular endothelial function,TCM symptom score and adverse reactions were compared between the two groups.Results The total effective rate of the observation group was higher than that of the control group,and the CTFC of left anterior descending branch,left circumflex branch and right coronary artery was lower than that of the control group after treatment,with statistically significant difference(P<0.05).The blood flow classification in the observation group was better than that in the control group(P<0.05).After treatment,the level of nitric oxide in the observation group was higher than that in the control group,and the level of endothelin-1 was lower than that in the control group,with statistically significant difference(P<0.05).After treatment,the scores of chest pain,chest tightness,palpitation,shortness of breath and fatigue in the observation group were lower than those in the control group,with statistically significant difference(P<0.05).There was no significant difference in total incidence of adverse reactions between the two groups(P>0.05).Conclusion Yangxin Huoxue recipe combined with trimetazidine can improve the treatment effect of CSF in the elderly,improve coronary CTFC,correct abnormal blood flow,reduce vascular endothelial function damage and reduce TCM symptom score,which is safe and reliable.

Coronary slow flowYangxin Huoxue recipeTrimetazidineBlood flow classificationVascular endothelial function

刘东梅

展开 >

山东省烟台市蓬莱中医医院老年病科,山东烟台 264000

冠状动脉慢血流 养心活血方 曲美他嗪 血流分级 血管内皮功能

2024

中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
年,卷(期):2024.14(14)